Clinical Report: Spatial Transcriptomic Analysis Identifies an Immune-Fibrotic Pathway

Overview

This study identifies an SPP1-associated immune-fibrotic niche in IgG4-related disease (IgG4-RD) through spatial transcriptomic analysis of submandibular gland tissues.

Background

IgG4-RD is a fibroinflammatory disorder that leads to significant organ damage and requires long-term management. Understanding the molecular mechanisms of fibrosis in this disease is important.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

• SPP1-expressing macrophages are enriched in fibrosis-high tissue regions.
• Fibrotic niches are characterized by COL1A1 expression and fibroblast signatures.
• Increased expression of PDGFB and TGF-β–related molecules correlates with fibrosis-related signatures.
• A preTfh-to-Tph axis is more pronounced in fibrosis-high lesions.
• Exhaustion-associated programs are linked to T-cell differentiation states and SPP1-related signatures.

Clinical Implications

The identification of SPP1-associated niches may inform strategies for disease stratification in IgG4-RD.

Conclusion

This study provides insights into the spatial dynamics of immune and fibrotic interactions in IgG4-RD.

Related Resources & Content

1. Frontiers | Spatial transcriptomics reveals an SPP1-centered immune–fibrotic axis associated with fibrosis-related tissue remodeling in IgG4-related disease
2. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease - PubMed
3. Clinical Rheumatology (Springer) — Identification of Th17-associated genes PGAP1 and TMBIM1 as promising biomarkers for diagnosis and prognosis in systemic sclerosis: Insights from bioinformatics and murine studies
4. Clinical Rheumatology — Discovery and validation of inflammatory markers in primary Sjögren’s syndrome
5. Clinical Rheumatology — Induced Pluripotent Stem Cell Generation and Differentiation Uncover Gene Expression Linked to Ankylosing Spondylitis Risk in Bone Progenitor Cells
6. Journal of Gastroenterology — Understanding the Diagnosis and Current Perspectives on IgG4-Related Disease in the Hepato-Biliary-Pancreatic Region
7. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease - PubMed
8. AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNA® (INEBILIZUMAB-CDON) FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE (IgG4-RD)
9. Frontiers | Spatial transcriptomics reveals an SPP1-centered immune–fibrotic axis associated with fibrosis-related tissue remodeling in IgG4-related disease